64 related articles for article (PubMed ID: 23469802)
1. [Roles of trichorhinophalangeal syndrome-1 gene in normal breast development and breast cancer].
Bao Y; Zhong ZX; Cui G; Guo L; Wang ZF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):121-4. PubMed ID: 23469802
[TBL] [Abstract][Full Text] [Related]
2. Expression and relevance of TRPS-1: a new GATA transcription factor in breast cancer.
Chen JQ; Bao Y; Litton J; Xiao L; Zhang HZ; Warneke CL; Wu Y; Shen X; Wu S; Katz RL; Sahin A; Bondy M; Murray JL; Radvanyi L
Horm Cancer; 2011 Apr; 2(2):132-43. PubMed ID: 21761336
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the trichorhinophalangeal syndrome-1 (TRPS-1), a GATA family transcription factor, in early-stage breast cancer.
Chen JQ; Bao Y; Lee J; Murray JL; Litton JK; Xiao L; Zhou R; Wu Y; Shen XY; Zhang H; Sahin AA; Katz RL; Bondy ML; Berinstein NL; Hortobagyi GN; Radvanyi LG
Ann Oncol; 2013 Oct; 24(10):2534-2542. PubMed ID: 23729783
[TBL] [Abstract][Full Text] [Related]
4. Quantitative immunohistochemical analysis and prognostic significance of TRPS-1, a new GATA transcription factor family member, in breast cancer.
Chen JQ; Litton J; Xiao L; Zhang HZ; Warneke CL; Wu Y; Shen X; Wu S; Sahin A; Katz R; Bondy M; Hortobagyi G; Berinstein NL; Murray JL; Radvanyi L
Horm Cancer; 2010 Feb; 1(1):21-33. PubMed ID: 21761348
[TBL] [Abstract][Full Text] [Related]
5. GATA-3 as a marker of hormone response in breast cancer.
Fang SH; Chen Y; Weigel RJ
J Surg Res; 2009 Dec; 157(2):290-5. PubMed ID: 19059610
[TBL] [Abstract][Full Text] [Related]
6. GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignancies.
Lin HY; Zeng D; Liang YK; Wei XL; Chen CF
Oncotarget; 2017 May; 8(21):34750-34761. PubMed ID: 28423734
[TBL] [Abstract][Full Text] [Related]
7. The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer.
Radvanyi L; Singh-Sandhu D; Gallichan S; Lovitt C; Pedyczak A; Mallo G; Gish K; Kwok K; Hanna W; Zubovits J; Armes J; Venter D; Hakimi J; Shortreed J; Donovan M; Parrington M; Dunn P; Oomen R; Tartaglia J; Berinstein NL
Proc Natl Acad Sci U S A; 2005 Aug; 102(31):11005-10. PubMed ID: 16043716
[TBL] [Abstract][Full Text] [Related]
8. GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value.
Voduc D; Cheang M; Nielsen T
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):365-73. PubMed ID: 18268121
[TBL] [Abstract][Full Text] [Related]
9. Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.
Cohen H; Ben-Hamo R; Gidoni M; Yitzhaki I; Kozol R; Zilberberg A; Efroni S
Breast Cancer Res; 2014 Nov; 16(6):464. PubMed ID: 25410484
[TBL] [Abstract][Full Text] [Related]
10. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
11. GATA3 protein as a MUC1 transcriptional regulator in breast cancer cells.
Abba MC; Nunez MI; Colussi AG; Croce MV; Segal-Eiras A; Aldaz CM
Breast Cancer Res; 2006; 8(6):R64. PubMed ID: 17078870
[TBL] [Abstract][Full Text] [Related]
12. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
13. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
14. Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.
Hollestelle A; Peeters JK; Smid M; Timmermans M; Verhoog LC; Westenend PJ; Heine AA; Chan A; Sieuwerts AM; Wiemer EA; Klijn JG; van der Spek PJ; Foekens JA; Schutte M; den Bakker MA; Martens JW
Breast Cancer Res Treat; 2013 Feb; 138(1):47-57. PubMed ID: 23338761
[TBL] [Abstract][Full Text] [Related]
15. Endoplasmic reticulum protein 29 regulates epithelial cell integrity during the mesenchymal-epithelial transition in breast cancer cells.
Bambang IF; Lee YK; Richardson DR; Zhang D
Oncogene; 2013 Mar; 32(10):1240-51. PubMed ID: 22543584
[TBL] [Abstract][Full Text] [Related]
16. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition.
Sultan AS; Brim H; Sherif ZA
Cancer Sci; 2008 Feb; 99(2):272-9. PubMed ID: 18271926
[TBL] [Abstract][Full Text] [Related]
17. Fog2 excision in mice leads to premature mammary gland involution and reduced Esr1 gene expression.
Manuylov NL; Smagulova FO; Tevosian SG
Oncogene; 2007 Aug; 26(36):5204-13. PubMed ID: 17310981
[TBL] [Abstract][Full Text] [Related]
18. Low trichorhinophalangeal syndrome 1 gene transcript levels in basal-like breast cancer associate with mesenchymal-to-epithelial transition.
Bao Y; Ruan LJ; Mo JF
Chin Med Sci J; 2013 Sep; 28(3):129-34. PubMed ID: 24074613
[TBL] [Abstract][Full Text] [Related]
19. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.
Kurebayashi J; Otsuki T; Kunisue H; Tanaka K; Yamamoto S; Sonoo H
Clin Cancer Res; 2000 Feb; 6(2):512-8. PubMed ID: 10690532
[TBL] [Abstract][Full Text] [Related]
20. Expression and mutational analysis of GATA3 in Malaysian breast carcinomas.
Bong PN; Zakaria Z; Muhammad R; Abdullah N; Ibrahim N; Emran NA; Syed Hussain SN
Malays J Pathol; 2010 Dec; 32(2):117-22. PubMed ID: 21329183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
